Verruca Vulgaris — Trials

Verruca Vulgaris — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07806617	Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts	active not recruiting	Phase 2	55	Rush University Medical CenterOTHER	1	Sep 15, 2026	clinicaltrials
NCT07637734	Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)(COVE-3)	recruiting	Phase 3	300	Verrica Pharmaceuticals Inc.INDUSTRY	2	Sep 3, 2026	clinicaltrials
NCT03977753	Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts(EVAsION)	recruiting	Phase 4	162	Labo'LifeINDUSTRY	1	Aug 31, 2026	clinicaltrials
NCT07448844

Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials